Study to Evaluate the Immune Response After Booster Vaccination With Tdap-IPV Vaccine (Against Tetanus, Diphtheria, Pertussis and Poliomyelitis) in Children Who Received Different Pertussis Primary Vaccine Regimens in Republic of South Africa
Clinical trial NCT04300192 · COMPLETED
Trial details
- NCT number
- NCT04300192
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-27
- Primary completion
- 2023-01-11
- Enrollment
- 273
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.